Organizing Chemotherapy and Hormonal Therapy: The Key Role of Supportive Agents

Last Modified: July 6, 2003

Share article

Conference Dates: February 5-6, 2004
Conference Location: Geneva, Switzerland

Sponsoring Group: MSKCC, Clinique de Genolier, Imedex

Conference Web Page URL:

Topics Covered: Conference Summary - Participants at this meeting will learn about new ways and means to optimize chemotherapy and hormonal therapy in cancer patients. Recent progress in antiemetic agents allows long term control of nausea and vomiting, not only acute phase control. New growth factors promise an easier erythropoietic and granulocytic support, and such support can be crucial for optimal outcomes. Bisphosphonates may have a role in adjuvant therapy, along with chemotherapy and hormonal agents. Decrease of mucositis and appropriate treatment of infectious complications in outpatients with solid tumours will also be discussed.

Registration Information: Online at (registration will open in September),tel: +1 770-751-7332, fax: +1 770-751-7334, email:

Continuing Education: Yes

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More